Synta Pharmaceuticals to Host Investigator Panel Session on New Clinical Opportunities for Hsp90 Inhibition in Oncology

LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that the Company will host a panel discussion on Friday, March 25, 2011 from 12:00 p.m. to 1:30 p.m. (ET) in New York.